http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1715062-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38821b2e65ea28d17d085883fefeacdd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2003-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c8d3368328b4e3ca9e7a17f51789e4d
publicationDate 2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1715062-A2
titleOfInvention Method for detecting human papillomavirus mRNA
abstract An in vitro method is provided for screening human female subjects to assess their risk of developing cervical carcinoma which comprises screening the subject for expression of mRNA transcripts from the E6 and optionally the L1 gene of human papillomavirus, wherein subjects positive for expression of L1 and/or E6 mRNA are scored as being at risk of developing cervical carcinoma. Kits for carrying out such methods are also provided.
priorityDate 2002-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9513399-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129245969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129475383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129561421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127922471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705

Total number of triples: 44.